The Microbiology of Respiratory System Infections Clinical Microbiology Diagnosis, treatment and prophylaxis of infections Series
Coordonnateurs : Kon Kateryna, Rai Mahendra
The Microbiology of Respiratory System Infections reviews modern approaches in the diagnosis, treatment, and prophylaxis of respiratory system infections. The book is very useful for researchers, scientists, academics, medical practitioners, graduate and postgraduate students, and specialists from pharmaceutical and laboratory diagnostic companies. The book has been divided into three sections according to the types of respiratory pathogens.
The first section contains reviews on the most common and epidemiologically important respiratory viruses, such as influenza virus, severe acute respiratory system coronavirus, and recently discovered Middle East respiratory syndrome coronavirus.
The second section is devoted to bacterial and fungal pathogens, which discusses etiology and pathogenesis including infections in patients with compromised immune system, and infections caused by fungal pathogens, such as Aspergillus and Pneumocystis.
The third section incorporates treatment approaches against different types of bacterial infections of the lower respiratory tract. This section reviews classical antimicrobial and phytomedical approaches as well as the application of nanotechnology against respiratory pathogens.
Chapter 1: Influenza virus infections: clinical update, molecular biology, and therapeutic options
Chapter 2: Influenza viral infection in the respiratory system—potential ways of monitoring
Chapter 3: SARS coronavirus infections of the lower respiratory tract and their prevention
Chapter 4: The middle east respiratory syndrome coronavirus respiratory infection: an emerging infection from the arabian peninsula
Chapter 5: Respiratory infections of the human bocavirus
Chapter 6: Circulation of respiratory pathogens at mass gatherings, with special focus on the Hajj pilgrimage
Chapter 7: Indoor air pollution due to mycoflora causing acute lower respiratory infections
Chapter 8: Is there a link between environmental allergens and parasitism?
Chapter 9: Respiratory infections in immunosuppressed patients
Chapter 10: Metallo-beta-lactamase producer Pseudomonas aeruginosa: an opportunistic pathogen in lungs
Chapter 11: Mycobacterium tuberculosis: clinical and microbiological aspects
Chapter 12: Pulmonary aspergillosis: diagnosis and treatment
Chapter 13: Laboratory diagnosis of Pneumocystis jirovecii pneumonia
Chapter 14: Antimicrobial approaches against bacterial pathogens which cause lower respiratory system infections
Chapter 15: Nanotechnological applications for the control of pulmonary infections
Chapter 16: Volatile oils: Potential agents for the treatment of respiratory infections
Chapter 17: Current therapeutics and prophylactic approaches to treat pneumonia
The target audience is researchers, scientists, teachers of universities, medical practitioners, graduate and postgraduate students in microbiology and the respiratory system.
Dr. Kon's scientific contributions include more than 100 publications, 6 books and 18 scientific articles. The main focus of Dr. Kon’s research is antibiotic resistance in bacteria, coping with microbial resistance by plant essential oils and nanoparticles, microbiology of surgical and gynaecological infections, application of different statistical methods to analysis of biomedical data.
Professor Mahendra Rai is a UGC-Basic Science Research Faculty Fellow and former head of the Department of Biotechnology, Sant Gadge Baba Amravati University, India. Presently, he is a visiting Scientist at the Department of Microbiology, Nicolaus Copernicus University, Poland. His areas of expertise include microbial biotechnology and nanobiotechnology. Currently, his group’s main research interest is green synthesis of metal nanoparticles particularly using fungi and their applications as nanoantimicrobials against pathogenic microbes. Prof. Rai has received several prestigious awards, including the Medini Award by the Government of India. He has been featured in Stanford’s list of the top 2% of scientists in nanoscience.
- Offers the most up to date information on the microbiology of lower respiratory system infections
- Features contributors from across the world, presenting questions of interest to readers of both developed and developing countries
- Reviews the most common and epidemiologically important respiratory viruses
- Discusses the etiology and pathogenesis of bacterial and fungal pathogens including infections in patients with compromised immune system, and infections caused by fungal pathogens, such as Aspergillus and Pneumocystis
Date de parution : 06-2016
Ouvrage de 312 p.
19x23.3 cm
Thème de The Microbiology of Respiratory System Infections :
Mots-clés :
ABPA; active tuberculosis; adjuvant; allergens; allergy; antibacterial activity; antigens; antiinflammation activity; antimicrobial; antiviral activity; Aspergillosis; Aspergillus fumigatus; asthma; bacteria; bacterial pathogens; bacterial pneumonia; carbapenemase; carriage; chronic respiratory infections; community-associated pneumonia; complications; coronavirus; current methods; diagnosis; drug resistance; ecology; eosinophilia; festival; fibrosis; Hajj; HBoV; health-care facilities; helminths; hemagglutinin; hematological malignancy; HP; human activity; human bocavirus; hygiene hypothesis; identification; immune response; immunity; immunosuppressed patient; infection; influenza; influenza A; influenza variants; interferon gamma release assays; latent tuberculosis; LRTI; lung pathology; lung infection; mass gathering; MERS-CoV; metallo-beta-lactamase; multidrug resistance; mycobacterium tuberculosis; mycobacterium tuberculosis culture; mycotoxin; nanomaterials; nanotechnology; natural compounds; natural medicine; neuraminidase; new alternatives; pandemics; parasites; parasitism; plants; Pneumocystis jirovecii; pneumonia; prevention; Pseudomonas aeruginosa; pulmonary infections; religious; respiratory disease; respiratory infections; SARS coronavirus; sensor; sick building spore trap; sport; sputum smear; standards; susceptibility testing antimycobacterial drugs; syndromic surveillance; Th1-Th2; Th1/Th2 paradigm; therapeutics; transmission; treatment therapies; tuberculin test; Umrah; URTI; vaccine; vaccines; viral fusion; viral pneumonia; virus; volatile oils; Voriconazole
